Failure of a randomized, double-blind, placebo-controlled study to evaluate the efficacy of H. pylori eradication in H. pylori -infected patients with functional dyspepsia

Gut and Liver

Volumn 5, Issue 4, 2011, Pages 468-471

  Hong, Su Jin ^a   Sung, In Kyung ^b   Kim, Jae Gyu ^c   Lee, Sang Woo ^d   Choi, Suck Chei ^e   Yang, Chang Hun ^f   Lee, Sang In ^g   Lee, Dong Ho ^h   Kim, Gwang Ha ⁱ   Jeon, Seong Woo ^j   Park, Moo In ^k   Park, Sue K ^l,m   Park, Byung Joo ^l   Seol, Sang Young ⁿ  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Wonkwang University School of Medicine   (South Korea)

^f Dongguk University College of Medicine   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

ⁱ Pusan National University School of Medicine   (South Korea)

^j Kyungpook National University School of Medicine   (South Korea)

^k Kosin University College of Medicine   (South Korea)

^l Seoul National University Hospital   (South Korea)

^m Seoul National University   (South Korea)

ⁿ Inje University College of Medicine   (South Korea)

more..

Author keywords

Dyspepsia; Helicobacter pylori; Symptom

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; PLACEBO;

ARTICLE; CASE REPORT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DYSPEPSIA; ERADICATION THERAPY; EVALUATION; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INTERVIEW; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

EID: 81855216309     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.4.468     Document Type: Article

References (13)

1. Mimidis K, Tack J. Pathogenesis of dyspepsia. Dig Dis 2008;26:194-202. (Pubitemid 351667801)
2. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781. (Pubitemid 46854190)
3. Fock KM, Katelaris P, Sugano K, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587-1600.
4. Moayyedi P, Soo S, Deeks J, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(2):CD002096.
5. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
6. Cho YK, Choi MG, Kim SH, et al. The effect of mosapride on quality of life in functional dyspepsia. Korean J Gastroenterol 2004;43:160-167.
7. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-840. (Pubitemid 43290921)
8. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
9. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-1376. (Pubitemid 41375189)
10. Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 2010;25:1151-1156.
11. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil 2010;16:148-156.
12. Yim JY, Kim N, Choi SH, et al. Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-340. (Pubitemid 47196330)
13. Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol 2010;45:567-572.